dacogen
janssen-cilag international n.v. - decitabinas - leukemija, mieloidas - antinavikiniai vaistai - suaugusių pacientų su naujai diagnozuota pirmine arba antrine ūmine mieloidine leukemija (Ūml) pagal pasaulio sveikatos organizacijos (pso) klasifikaciją, kuriems netinka standartinė indukcinė chemoterapija.
inaqovi
otsuka pharmaceutical netherlands b.v. - cedazuridine, decitabine - leukemija, mieloidas - antinavikiniai vaistai - inaqovi is indicated as monotherapy for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) who are ineligible for standard induction chemotherapy.
venclyxto
abbvie deutschland gmbh co. kg - venetoclax - leukemija, limfocitinė, lėtinė, b-ląstelė - antinavikiniai vaistai - venclyxto in combination with obinutuzumab is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (cll) (see section 5. venclyxto in combination with rituximab is indicated for the treatment of adult patients with cll who have received at least one prior therapy. venclyxto monotherapy is indicated for the treatment of cll:- in the presence of 17p deletion or tp53 mutation in adult patients who are unsuitable for or have failed a b cell receptor pathway inhibitor, or- in the absence of 17p deletion or tp53 mutation in adult patients who have failed both chemoimmunotherapy and a b-cell receptor pathway inhibitor. venclyxto in combination with a hypomethylating agent is indicated for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) who are ineligible for intensive chemotherapy.
gemcitabine sanoswiss
sanoswiss, uab - gemcitabinas - milteliai infuziniam tirpalui - 1000 mg; 200 mg - gemcitabine
gemcitabine kabi
fresenius kabi polska sp.z.o.o. - gemcitabinas - koncentratas infuziniam tirpalui - 38 mg/ml; 40 mg/ml - gemcitabine
gemcitabine stada
stada arzneimittel ag - gemcitabinas - koncentratas infuziniam tirpalui - 38 mg/ml - gemcitabine
gemcitabine accord
accord healthcare b.v. - gemcitabinas - milteliai infuziniam tirpalui - 2000 mg; 200 mg; 1000 mg - gemcitabine
gemcitabine accord
accord healthcare b.v. - gemcitabinas - koncentratas infuziniam tirpalui - 100 mg/ml - gemcitabine
gemcitabine medac
medac gesellschaft für klinische spezialpräparate mbh - gemcitabinas - milteliai infuziniam tirpalui - 38 mg/ml - gemcitabine
gemcitabine actavis
actavis group ptc ehf. - gemcitabinas - milteliai infuziniam tirpalui - 38 mg/ml - gemcitabine